Profil
Mats Lindskog currently works at OncoZenge AB, as Independent Director from 2025.
Mr. Lindskog also formerly worked at ACAP Invest AB, as Chief Executive Officer in 2012.
Mr. Lindskog received his graduate degree and doctorate degree from Royal Institute of Technology and undergraduate degree from Blekinge Tekniska Högskola.
Postes actifs de Mats Lindskog
| Sociétés | Poste | Début |
|---|---|---|
| ONCOZENGE AB | Directeur/Membre du Conseil | 01/01/2025 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Corporate Officer/Principal | - |
Anciens postes connus de Mats Lindskog
| Sociétés | Poste | Fin |
|---|---|---|
| WNTRESEARCH AB | Directeur/Membre du Conseil | - |
| ACAP INVEST AB | Directeur Général | - |
Formation de Mats Lindskog
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
ACAP Invest AB
ACAP Invest AB Investment Trusts/Mutual FundsMiscellaneous Provides investment services | Miscellaneous |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wntresearch AB
Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Blekinge Tekniska Högskola
Blekinge Tekniska Högskola Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
OncoZenge AB
OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
















